Capricor Therapeutics, Inc
- Biotech or pharma, therapeutic R&D
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused development of innovative cell and exosome-based therapies for the treatment of rare diseases.